FDA Awards 19 Grants for Rare Disease Research
On October 17, 2022, the FDA announced that its Orphan Products Grants Program has awarded 19 grants and 2 contracts, amounting to over $38 million, for rare disease research. This action will...Etripamil Phase III Clinical Trials Are Successful
Milestone Pharmaceuticals recently announced positive test results from a phase III clinical trial of etripamil, a calcium channel blocker to treat paroxysmal supraventricular tachycardia (PSVT). PSVT...Bridging Surgical Treatment and Chemoradiation for Glioblastoma Patients
On October 11, 2022, GT Medical announced the first participant enrolled in the GammaTile Enhanced Stupp ALTernative (GESTALT) trial. While this trial is still in its infancy, if the results are favorable, it may influence protocols for...Orexo Pharmaceuticals Announces Phase I Clinical Study Data
Months after announcing the development of a nasal epinephrine rescue medication, Orexo Pharmaceuticals announced positive phase I clinical trial data on the drug — called OX640. Epinephrine is a...Diversifying Clinical Trials through Telehealth Platforms
In a recent press release, Ro — a healthcare company — announced that it will partner with the National Institute of Aging, a subset of the NIH, to use its telehealth platform to diversify...How Excluding Disabled Populations from Clinical Trials Impacts Care
Using data from ClinicalTrials.gov, researchers collected data on eligibility criteria from approximately 100 clinical research protocols. Of the 97 interventional studies, 14 focused on dementia, 24...J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission
Johnson & Johnson announced positive results from the VEGA Phase 2 clinical trial that paired the monoclonal antibody Tremfya (guselkumab) and the immunosuppressive drug Simponi (golimumab). The...Walmart Launches Clinical Research Mission
Today, Walmart joined many other companies to improve clinical research for marginalized communities by launching its clinical research mission. The Walmart Healthcare Research Institute (WHRI) will be...COVID-19 Vaccination Alters Menstrual Cycle Length
As the COVID-19 pandemic continues and vaccinations continue to be advanced, many patients are concerned about vaccine side effects. Multiple sources have perpetuated the misconception that COVID-19...Combining Existing Drugs Introduced New Parkinson’s Disease Treatment
The National Institute of Neurological Disorders and Stroke, a subset of the NIH, estimates that nearly one million people in the United States have Parkinson’s disease. Considering the ever-aging population and the increased risk of...Sponsored by Glooko
How Digital Companions, Therapeutics Are Changing Healthcare
Thanks to the 2020 COVID-19 pandemic, the medical industry has been hurled into a digital healthcare environment to support and provide care to patients while social distancing, leading to improved...FDA Approved Psilocybin Investigational New Drug Application
Psilocybin has become increasingly popular in pharmaceutical research to treat multiple neurological and mental health conditions. The FDA recently approved an investigational new drug (IND)...Amgen’s Immunotherapy for Lung Cancer Reduces Disease Progression by 34%
Results from the Phase III CodeBreaK 200 clinical trial found that Amgen’s targeted therapy Lumakras successfully extended progression-free survival (PFS) by about two months and was 15% more...Sponsored by Glooko
Democratizing Access to Clinical Trials through Remote Patient Monitoring
Digital monitoring techniques quickly embraced during the COVID-19 pandemic are changing the relationship between clinical trials and patients, paving the way to increased enrollment, greater patient...Paxlovid Advantageous for Elderly COVID-19 Patients, Ineffective in Younger Adults
A study published on September 1st in the New England Journal of Medicine tracking health data from 109,254 Israeli adults found a 73% reduction in hospitalization and a 79% reduction in COVID-19...Sponsored by Glooko
